CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
CONMED Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$46.05−0.67 (-1.43%)
Close on Oct 19, 2026
- Market cap
- $1.39B
- P/E (TTM)
- 30.5
- Dividend yield
- 1.30%
Share price
+$0.86 (+1.90%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
CONMED Corp grew revenue 5.2% to $1.37B over the twelve months to Dec 31, 2025. Operating income fell 48.8% to $102.62M, moving the operating margin from 15.3% to 7.5%. Free cash flow was $150.88M, down 2.0% from a year earlier.
Revenue
$1.37B
+5.2% vs. a year earlier
Operating income
$102.62M
-48.8% vs. a year earlier
Free cash flow
$150.88M
-2.0% vs. a year earlier
EPS, diluted
$1.51
-64.5% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.39B
- P/E ratio
- 30.5
- Price to sales
- 1.01
- Price to book
- 1.33
- Dividend yield
- 1.30%
- Free cash flow yield
- 10.88%
Fundamentals
- Revenue
- $1.37B
- Net income
- $47.06M
- EPS, diluted
- $1.51
- Free cash flow
- $150.88M
- Book value per share
- $34.58
- Diluted shares
- 30M
Fifteen years at a glance
Fiscal years 2011 to 2025, USD
Revenue
$1.37B+5.2% YoY
Gross profit
$750.48M+2.4% YoY
Operating income
$102.62M-48.8% YoY
Net income
$47.06M-64.5% YoY
EPS, diluted
$1.51-64.5% YoY
Free cash flow
$150.88M-2.0% YoY
Reported period